Further observations on the role of Staphylococcus aureus exotoxins and IgE in the pathogenesis of nasal polyposis

Laryngoscope

Volumn 121, Issue 3, 2011, Pages 647-655

  Bernstein, Joel M ^a   Allen, Cheryl ^b   Rich, Gary ^b   Dryja, Diane ^c   Bina, Paul ^d   Reiser, Raoul ^d   Ballow, Mark ^b   Wilding, Gregory E ^e  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

^c GATES VASCULAR INSTITUTE AT KALEIDA HEALTH   (United States)

^d Toxin Technology   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

chronic inflammation; IgE; Nasal polyposis; Staphylococcus aureus exotoxins

Indexed keywords

BACTERIAL TOXIN; CD3 ANTIGEN; IMMUNOGLOBULIN E; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; INFLAMMATION; NONHUMAN; NOSE MUCUS; NOSE POLYP; OBSERVATIONAL METHOD; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL TECHNIQUE; T LYMPHOCYTE; TOXIC SHOCK SYNDROME; UPREGULATION;

AGED; ANTIGENS, CD3; BACTERIAL TOXINS; ENTEROTOXINS; EXOTOXINS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REFERENCE VALUES; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES; UP-REGULATION;

EID: 79951925174     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21400     Document Type: Article

References (26)

1. Pawankar R, Nonaka M,. Inflammatory mechanisms and remodeling in chronic rhino- sinusitis with nasal polyps. Curr Allergy Asthma Rep 2007; 7: 202-208. (Pubitemid 46784199)
2. Bernstein JM,. The molecular biology of nasal polyposis. Curr Allergy Asthma Rep 2001; 1: 262-267.
3. Lee CH, Rhee CS, Min YG,. Cytokine gene expression in nasal polyps. Ann Otol Rhinol Laryngol 1998; 107: 655-670.
4. Pawankar R,. Nasal polyposis: an update: an editorial review. Curr Opin Allergy Clin Immunol 2003; 3: 1-6. (Pubitemid 36159341)
5. Bernstein JM,. Update on the molecular biology of nasal polyposis. Otolaryngol Clin North Am 2005; 38: 1243-1255. (Pubitemid 41737835)
6. Kingdom TT, Swain RE,. The microbiology and antimicrobial resistance patterns in chronic rhinosinusitis. Am J Otolaryngol 2004; 25: 323-328. (Pubitemid 39149942)
7. Bachert C, Zhang M, van Zele T, Gevaert P, Patou J, van Cauwenberge P,. Staphylococcus aureus enterotoxins as immune stimulants in chronic rhinosinusitis. Clin Allergy Immunol 2007; 20: 163-175.
8. Bernstein JM, Ballow M, Schlievert PM, Rich G, Allen C, Dryja D,. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2003; 17: 321-326. (Pubitemid 38128686)
9. Seiberling KA, Grammer L, Kern RC,. Chronic rhinosinusitis and superantigens. Otolaryngol Clin North Am 2005; 38: 1215-1236. (Pubitemid 41737833)
10. Seiberling KA, Conley DB, Tripathi A, et al. Superantigens and chronic rhinosinusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005; 115: 1580-1585. (Pubitemid 41330665)
11. Alouf JE, Muller-Alouf H,. Staphylococcal and Streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol 2003; 292: 429-440. (Pubitemid 36258454)
12. Mourad W, Scholl P, Diaz A, et al. The Staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T-B cell interaction. J Exp Med 1989; 170: 2011-2022. (Pubitemid 20010081)
13. Bachert C, Gevaert T, Holtappe LS, et al. Total and specific IgE in nasal polyps related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607-614. (Pubitemid 32397745)
14. Isenberg HD,. Clinical Microbiology Procedures Handbook. 2nd Ed. Washington, DC: ASM Press; 2004; 8.4: 1-6.
15. Schlievert PM,. Immunochemical assays for toxic shock syndrome toxin-1. Methods Enzymol 1988; 165: 339-344. (Pubitemid 19014369)
16. Wang SY, Hsu ML, Tzeng CH, Hsu HC, Ho CK,. The influence of cryopreservation on cytokine production by human T-lymphocytes. Cryobiology 1998; 37: 22-29.
17. McKay DM, Singh PK,. Superantigen activation of immune cells evoke epithelial (T84) transport and barrier abnormalities via IFN-Î and TNF-α. J Immunol 1997; 159: 2832-2390.
18. Damm M, Quante G, Rosenbohm J, et al. Proinflammatory effects of Staphylococcus aureus exotoxin B on nasal epithelial cells. Otolaryngol Head Neck Surg 2006; 134: 245-249. (Pubitemid 43187124)
19. Herman A, Kappler JW, Marrack P, Pullen AM,. Superantigen: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9: 745-772.
20. Bernal A, Kroft T, Fraser JD, et al. Superantigens in human disease. J Clin Immunol 1999; 19: 149-157. (Pubitemid 29318688)
21. Gould HJ, Takhar P, Harries HE, et al. The allergic march from Staphylococcus aureus superantigens to immunoglobulin E. Clin Immunol Allergy 2007; 93: 106-136. (Pubitemid 46924875)
22. Galli SJ, Gordon JR, Wershil BK,. Mast cell cytokines in allergy and inflammation. Agents Actions 1993; 49: 209-220. (Pubitemid 23210132)
23. Rossi RE, Monasterolo G,. Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SEA, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis. Int Arch Allergy Immunol 2004; 133: 261-266. (Pubitemid 38529219)
24. Hofer MF, Lester MR, Schlievert PM, Leung DY,. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Immunol 1995; 25: 1218-1227. (Pubitemid 26015232)
25. Bachert C, Gevaert P, Howarth P, Holtappels G, van Cauwenberge P, Johansson SG,. IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol 2003; 111: 1131-1132. (Pubitemid 36570878)
26. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M,. Trends Immunol 2001; 22: 199-204.